Forum Financial Management LP Boosts Stock Holdings in CVS Health Corporation $CVS

Forum Financial Management LP boosted its stake in shares of CVS Health Corporation (NYSE:CVS) by 3.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,525 shares of the pharmacy operator’s stock after purchasing an additional 490 shares during the period. Forum Financial Management LP’s holdings in CVS Health were worth $1,140,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of CVS. Ethic Inc. raised its stake in shares of CVS Health by 1.5% in the 2nd quarter. Ethic Inc. now owns 33,551 shares of the pharmacy operator’s stock valued at $2,298,000 after acquiring an additional 505 shares during the period. Brookstone Capital Management raised its stake in shares of CVS Health by 21.1% in the 2nd quarter. Brookstone Capital Management now owns 88,296 shares of the pharmacy operator’s stock valued at $6,091,000 after acquiring an additional 15,401 shares during the period. Citizens & Northern Corp raised its stake in shares of CVS Health by 2.9% in the 2nd quarter. Citizens & Northern Corp now owns 28,324 shares of the pharmacy operator’s stock valued at $1,954,000 after acquiring an additional 804 shares during the period. D.A. Davidson & CO. raised its stake in shares of CVS Health by 12.9% in the 2nd quarter. D.A. Davidson & CO. now owns 204,761 shares of the pharmacy operator’s stock valued at $14,124,000 after acquiring an additional 23,403 shares during the period. Finally, Cullen Frost Bankers Inc. raised its stake in shares of CVS Health by 7.7% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 6,190 shares of the pharmacy operator’s stock valued at $427,000 after acquiring an additional 444 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Price Performance

Shares of CVS stock opened at $81.07 on Friday. The firm has a market cap of $102.82 billion, a P/E ratio of 22.64, a P/E/G ratio of 0.90 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $83.52. The firm has a fifty day moving average of $75.31 and a two-hundred day moving average of $68.57.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period last year, the business earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is currently 74.30%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on CVS shares. Robert W. Baird raised shares of CVS Health from a “neutral” rating to an “outperform” rating and raised their target price for the company from $71.00 to $82.00 in a research note on Thursday, August 14th. Leerink Partners raised their target price on shares of CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 16th. UBS Group raised shares of CVS Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $67.00 to $79.00 in a report on Monday, August 18th. Morgan Stanley raised their price target on shares of CVS Health from $82.00 to $89.00 and gave the company an “overweight” rating in a report on Tuesday, October 14th. Finally, Cowen reaffirmed a “buy” rating on shares of CVS Health in a report on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $82.57.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.